Skip to main content

Rokos Capital Management LLP

Position in BSX — Boston Scientific Corp

CIK 1666335 LONDON, X0

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$8,795,228 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
2 quarters on record

Derivatives in BSX

reported options exposure · as of Jun 30, 2026
CallValue
$19,632,800
CallShares
460,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

All Filings in BSX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,632,800 460,000
2026-03-31 $1,016,550 16,200
2026-03-31 $1,016,550 16,200
2026-03-31 $8,795,228 140,163